Workflow
Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025
GlobeNewswire· 2025-04-30 20:05
CEA-targeted ISAC elicits complete responses in mice and is well-tolerated in NHPs PD-L1 ISAC directly activates and reprograms PD-L1-expressing myeloid cells in the TME to drive complete responses and immunological memory REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced preclinical results from its next-generation Boltbody™ ISACs targeting CEA ...
Enovix Announces First Quarter 2025 Financial Results
GlobeNewswire· 2025-04-30 20:05
FREMONT, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, announced today financial results for the first quarter 2025, which included the summary below from its President and CEO, Dr. Raj Talluri. Fellow Shareholders, In the first quarter of 2025, Enovix advanced across critical milestones with our lead smartphone customer, keeping us on track for a customer product launch later this year. We also strengthened our leadership ...
Climb Global Solutions Reports First Quarter 2025 Results
GlobeNewswire· 2025-04-30 20:05
Net Sales up 49% to $138.0 Million; Net Income up 35% to $3.7 Million or $0.81 per Share; Adjusted EBITDA (non-GAAP) up 38% to $7.6 MillionEATONTOWN, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- Climb Global Solutions, Inc. (NASDAQ:CLMB) (“Climb” or the “Company”), a value-added global IT channel company providing unique sales and distribution solutions for innovative technology vendors, is reporting results for the first quarter ended March 31, 2025. First Quarter 2025 Summary vs. Same Year-Ago Quarter Net sal ...
Iridex to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire· 2025-04-30 20:05
MOUNTAIN VIEW, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company plans to release financial results for the first quarter 2025 and provide a business update after the close of trading on Tuesday, May 13, 2025. The Company’s management team will host a corresponding conference call ...
Cipher Mining Announces Date of First Quarter 2025 Business Update Conference Call
GlobeNewswire· 2025-04-30 20:05
NEW YORK, April 30, 2025 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”) today announced it will provide a business update and release its first quarter 2025 financial results before U.S. markets open on Tuesday, May 6, 2025. Cipher will host a conference call and webcast that day at 8:00 a.m. Eastern Time. The live webcast and a webcast replay of the conference call can be accessed from the investor relations section of Cipher’s website at https://investors.ciphermining.co ...
Robinhood Reports First Quarter 2025 Results
GlobeNewswire· 2025-04-30 20:05
Revenues up 50% year-over-year to $927 million Net Deposits grow to a record $18.0 billion, and Robinhood Gold Subscribers reached a record 3.2 million Net Income up 114% year-over-year to $336 million Diluted EPS up 106% year-over-year to $0.37 Board of directors increases share repurchase authorization by $500 million to $1.5 billion MENLO PARK, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) today announced financial results for the first quarter of 2025, w ...
Pulmonx Reports First Quarter 2025 Financial Results
GlobeNewswire· 2025-04-30 20:05
REDWOOD CITY, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today reported financial results for the first quarter of 2025 ended March 31, 2025. Recent Highlights Achieved worldwide revenue of $22.5 million in the first quarter of 2025, a 20% increase over the same period last year and an increase of 21% on a constant currency basisDelivered $8.3 million in international revenue i ...
Vaxart to Present at the Citizens Life Sciences Conference
GlobeNewswire· 2025-04-30 20:05
SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (NASDAQ: VXRT) today announced that members of the management team will present at the Citizens Life Sciences conference taking place May 7-8, 2025. Presentation Details:Date and Time: Wednesday, May 7 at 1:00 PM ETWebcast: Click Here A live webcast will be available on the Company’s website at www.vaxart.com, and a replay of the presentation will be available for 30 days following the conclusion of the event. Institutional investo ...
SEALSQ Announces Agenda of its 2025 Annual General Meeting of Shareholders
GlobeNewswire· 2025-04-30 20:05
Geneva, Switzerland, April 30, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (“SEALSQ” or “the Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, is pleased to announce that its 2025 Annual General Meeting (“AGM”) of Shareholders will be held on May 19, 2025, at 09:00 a.m. Eastern Standard Time. The meeting will take place in person at Studio Gather, at 45 Rockefeller Plaza, 27th Floor, New York, New York 10020. ...
Pathfinder Bancorp, Inc. Announces Financial Results for First Quarter 2025
GlobeNewswire· 2025-04-30 20:05
Pathfinder Bank’s parent company earned $0.41 per diluted share on improving operating efficiency and growth in net interest income, net interest margin, core deposits and commercial loansOSWEGO, N.Y., April 30, 2025 (GLOBE NEWSWIRE) -- Pathfinder Bancorp, Inc. (“Pathfinder” or the “Company”) (NASDAQ: PBHC) announced its financial results for the first quarter ended March 31, 2025. The holding company for Pathfinder Bank (“the Bank”) earned net income attributable to common shareholders of $3.0 million or $ ...